Veterinary CRO & CDMO Market Size is Projected to be USD 15.2 Billion by 2034; Rising Need for more Veterinary Drugs is Boosting the Market Expansion

Veterinary CROs and CDMOs offer comprehensive services for animal health development, including preclinical studies, clinical trials, regulatory affairs, and data management, focusing on the research and development phase. The increased pet ownership, the need for more veterinary drugs, technological advancements, stricter regulations, and rising prevalence of animal diseases, is contributing in fueling the veterinary CRO & CDMO market growth.

Veterinary CRO & CDMO Market Segmentation Analysis:

By Animal Type	Companion Animals and Livestock Animals
By Service	Discovery, Development, Manufacturing, Packaging and Labeling, and Market Approval and Post-Marketing
By Application	Medicines and Medical Devices

Veterinary CRO & CDMO Market Report Highlights:

• Veterinary CRO & CDMO market size accounted for USD 6.69 Billion in 2024
• Target Market estimated to be USD 15.2 Billion by 2034 and to register a CAGR of 9.5%.
• Based on animal type, the companion animals segment holds the largest veterinary CRO & CDMO market share.
• By service, the discovery segment is attributed to dominate the market.
• According to application, the medicines segment is projected to lead the market.
• By region, the veterinary CRO & CDMO market is expected to expand rapidly in North America region.

Veterinary CRO & CDMO Market Dynamics:

Growing Factor	Challenge Factor	Market Trend
Growing Awareness Of Animal Health	Challenges Faced During Supply Chain Disruptions	Integration Of Advanced Technologies With Veterinary CRO & CDMO

Veterinary CRO & CDMO Market Key Highlights:

• In October 2024, the biotechnology company Archivel Farma, a member of CATALONIA.HEALTH, announced the opening of a business line as the Contract Development and Manufacturing Organization (CDMO). The initiative would focus on the manufacture of clinical batches under Good Manufacturing Practices (GMP), especially oriented to biological, sterile, lyophilized products, both for human and veterinary use.

Veterinary CRO & CDMO Market Report Analysis:

The Discovery Phase of the Drugs

The company conducts a marketing assessment to identify unmet animal health needs and guide scientists in developing novel chemistry, antigens, or innovative technology. The chemistry laboratory synthesizes similar molecules or materials, screening against key targets to find a lead candidate. Innovation considerations include intellectual property, ease of manufacture, proof-of-concept studies, API stability, animal safety, and toxicology studies.

Browse ∼40 market data tables and ∼35 figures through ∼160 slides and in-depth TOC on “Veterinary CRO & CDMO Market, By Animal Type (Companion Animals and Livestock Animals), Service (Discovery, Development, Manufacturing, Packaging and Labeling, and Market Approval and Post-Marketing), Application (Medicines and Medical Devices), and Region - Trends, Analysis, and Forecast till 2034”

For more insights into the Veterinary CRO & CDMO Market and its future trends, visit the link: https://www.prophecymarketinsights.com/market_insight/veterinary-cro-and-cdmo-market-5543

Competitive Landscape of Veterinary CRO & CDMO Market:

The major players competing the veterinary CRO & CDMO market are Labcorp Drug Development, Oncovet Clinical Research (OCR), Charles River Laboratories, Clinvet, Klifovet GmbH, Knoell Triveritasm, Vetspin, and Inotiv.

Company Name	Labcorp
Headquarter	North Carolina, U.S.
CEO	Mr. Adam H. Schechter
Employee Count (2024)	67,000 Employees